Amicus Therapeutics (FOLD) Insider Trading & Ownership $8.01 +0.28 (+3.62%) Closing price 04:00 PM EasternExtended Trading$7.92 -0.09 (-1.06%) As of 05:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Amicus Therapeutics (NASDAQ:FOLD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.20%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$343.36K Get FOLD Insider Trade Alerts Want to know when executives and insiders are buying or selling Amicus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FOLD Insider Buying and Selling by Quarter Amicus Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/19/2025Bradley L CampbellCEOSell400$10.00$4,000.00 12/2/2024Bradley L CampbellCEOSell7,500$10.02$75,150.00 11/6/2024Bradley L CampbellCEOSell7,901$12.50$98,762.50 11/1/2024Bradley L CampbellCEOSell7,500$11.46$85,950.00 10/1/2024Bradley L CampbellCEOSell7,500$10.60$79,500.00 (Data available from 1/1/2013 forward) FOLD Insider Trading Activity - Frequently Asked Questions Who is on Amicus Therapeutics' Insider Roster? The list of insiders at Amicus Therapeutics includes Bradley L Campbell, Daphne Quimi, David Michael Clark, Ellen Rosenberg, Jeff Castelli, John F Crowley, Margaret G Mcglynn, Michael Raab, and Samantha Prout. Learn more on insiders at FOLD. What percentage of Amicus Therapeutics stock is owned by insiders? 2.20% of Amicus Therapeutics stock is owned by insiders. Learn more on FOLD's insider holdings. Which Amicus Therapeutics insiders have been selling company stock? The following insiders have sold FOLD shares in the last 24 months: Bradley L Campbell ($1,318,419.25), David Michael Clark ($81,354.00), Ellen Rosenberg ($501,850.00), Jeff Castelli ($231,875.00), John F Crowley ($2,362,715.70), Margaret G Mcglynn ($100,500.00), and Samantha Prout ($537,964.00). How much insider selling is happening at Amicus Therapeutics? Insiders have sold a total of 405,570 Amicus Therapeutics shares in the last 24 months for a total of $5,134,677.95 sold. Amicus Therapeutics Key ExecutivesMr. Bradley L. Campbell M.B.A. (Age 48)CEO, President & Director Compensation: $984.09kMs. Ellen S. Rosenberg (Age 61)Chief Legal Officer & Corporate Secretary Compensation: $733.94kMr. David M. Clark (Age 49)Chief People Officer Compensation: $701.39kDr. Jeffrey P. Castelli (Age 52)Chief Development Officer Compensation: $709.64kMr. Simon Nicolas Reade Harford (Age 64)Chief Financial Officer Ms. Samantha Prout (Age 46)Chief Accounting Officer & Controller Dr. Jill Weimer Ph.D.Chief Science OfficerAndrew FaughnanSenior Director of Investor RelationsMr. Patrik S. Florencio Esq.Global Chief Compliance & Risk OfficerMs. Diana MooreHead of Global Corporate Communications More Insider Trading Tools from MarketBeat Related Companies MDGL Insider Trades HALO Insider Trades RGEN Insider Trades ALKS Insider Trades LGND Insider Trades MNKD Insider Trades BCRX Insider Trades CLDX Insider Trades NVAX Insider Trades INVA Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles $100 Million Buyback in Upwork Stock Follows a Strong Quarter Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in Outlook This page (NASDAQ:FOLD) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredFree: The Crypto Summit That Could Change Your LifeWall Street’s Crypto Playbook—Revealed at This Free Event If you want to understand what's really happening...Crypto 101 Media | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amicus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amicus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FOLD Stock Alerts